NCT06843681 2025-11-28Trastuzumab Plus Taxane Neoadjuvant Therapy for HER2-Positive Breast Ductal Carcinoma In Situ (DCIS) : A Phase II StudySun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 2 Enrolling by invitation54 enrolled